Q-Line Biotech Limited operates in the In-Vitro Diagnostics (IVD) industry and manufactures as well as trades diagnostic reagents, kits, instruments, consumables, and pathology equipment. The company earns revenue through sales of biochemistry reagents, rapid test kits, ELISA kits, molecular diagnostics products, and diagnostic instruments. These products are widely used in hospitals, pathology laboratories, diagnostic centres, ICUs, and healthcare institutions for disease detection, monitoring, and preventive healthcare solutions.

Q-Line Biotech an Book Built Issue, amounting to ₹ 214.48 Crore,consisting entirely an Fresh Issue of 0.63 crore shares of ₹ 214.48 Crore, The subscription period for the Q-Line Biotech IPO opens on May 21, 2026, and close on May 25, 2026. The allotment is expected to be finalized on or about May 26, 2026, Tuesday, and the shares will be listed on the NSE SME with a tentative listing date set on or about Friday, May 29, 2026.

The Share Price Band of Q-Line Biotech IPO is set at ₹326 to ₹343 per share  per equity share. The Market Capitalisation of the Q-Line Biotech at IPO price of ₹343  per equity share will be ₹800.16 Cr. The lot size of the IPO is 400 shares. Retail investors are required to invest a minimum of ₹ 274,400, 2 lots ( 800 Shares), while the minimum investment for High-Net-Worth Individuals (HNIs) is 3 lots ( 1,200 shares), amounting to ₹ 411,600.

HEM SECURITIES LIMITED, SHARE INDIA CAPITAL SERVICES PRIVATE LIMITED the book running lead manager of the Q-Line Biotech Ltd. while PURVA SHAREGISTRY (INDIA) PRIVATE LIMITED is the registrar for the issue.The Market Maker of the company is Hem Finlease Pvt.Ltd.

Q-Line Biotech Limited IPO GMP Today
The Grey Market Premium of Q-Line Biotech IPO is expected to be ₹51 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Q-Line Biotech Limited IPO Live Subscription Status Today: Real-Time Update
The subscription period for the Q-Line Biotech IPO opens on May 21, 2026

Q-Line Biotech Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online
Q-Line Biotech IPO allotment date is May 26, 2026, Tuesday, Q-Line Biotech IPO Allotment will be out on May 26, 2026, Tuesday, and will be live on Registrar Website from the allotment date.
PURVA SHAREGISTRY (INDIA) PRIVATE LIMITED IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Q-Line Biotech IPO from the dropdown list of IPO
- Enter your application number, PAN, or DP Client ID
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.

Objectives of Q-Line Biotech Limited IPO
Q-Line Biotech to utilise the Net Proceeds towards the following objects:
1. ₹9350.00 Lakhs is required for To meet Working Capital requirements
2. ₹9000.00 Lakhs is required for Repayment of certain borrowing availed by our Company, in part or full
3. General Corporate Purposes.

Refer to Q-Line Biotech Limited RHP for more details about the Company.